US equities
|
GOOGL
$283.82
▼-12.64%
GOOG
$282.32
▼-12.29%
MU
$934.27
▼-4.98%
MSFT
$530.14
▼-0.16%
AMZN
$243.79
▼-4.25%
META
$624.52
▲+1.96%
NVDA
$213.66
▼-0.80%
AAPL
$348.91
▲+1.48%
GOOGL
$283.82
▼-12.64%
GOOG
$282.32
▼-12.29%
MU
$934.27
▼-4.98%
MSFT
$530.14
▼-0.16%
AMZN
$243.79
▼-4.25%
META
$624.52
▲+1.96%
NVDA
$213.66
▼-0.80%
AAPL
$348.91
▲+1.48%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Cadrenal Therapeutics, Inc. - Common Stock
(NQ:
CVKD
)
0.9434
-0.0045 (-0.47%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cadrenal Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Stocks That Hit 52-Week Lows On Tuesday
↗
January 24, 2023
During Tuesday, 17 stocks hit new 52-week lows.
Via
Benzinga
Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
January 24, 2023
Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in...
Via
Benzinga
What's Going On With Cadrenal Therapeutics Stock Today
↗
January 23, 2023
Via
Benzinga
US Stocks Mostly Higher; Synchrony Financial Earnings Top Views
↗
January 23, 2023
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 90 points on Monday.
Via
Benzinga
Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
January 23, 2023
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 444.4% to $1.47 after the company announced it successfully completed the review of results from Milestone 7, a phase of its...
Via
Benzinga
< Previous
1
2
3
4
Next >